CA2805978C - Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition - Google Patents

Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition Download PDF

Info

Publication number
CA2805978C
CA2805978C CA2805978A CA2805978A CA2805978C CA 2805978 C CA2805978 C CA 2805978C CA 2805978 A CA2805978 A CA 2805978A CA 2805978 A CA2805978 A CA 2805978A CA 2805978 C CA2805978 C CA 2805978C
Authority
CA
Canada
Prior art keywords
antibody
activated
cough
potentiated form
potentiated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2805978A
Other languages
English (en)
French (fr)
Other versions
CA2805978A1 (en
Inventor
Oleg Iliich Epshtein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44899162&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2805978(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from RU2010130352/15A external-priority patent/RU2528093C2/ru
Priority claimed from RU2011125992/15A external-priority patent/RU2529783C2/ru
Application filed by Individual filed Critical Individual
Publication of CA2805978A1 publication Critical patent/CA2805978A1/en
Application granted granted Critical
Publication of CA2805978C publication Critical patent/CA2805978C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39583—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials not provided for elsewhere, e.g. haptens, coenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2805978A 2010-07-21 2011-07-15 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition Expired - Fee Related CA2805978C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
RU2010130352 2010-07-21
RU2010130352/15A RU2528093C2 (ru) 2010-07-21 2010-07-21 Фармацевтическая композиция и способ лечения острых и хронических заболевания дыхательной системы и синдрома кашля
RU2011125992/15A RU2529783C2 (ru) 2011-06-24 2011-06-24 Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля
RU2011125992 2011-06-24
PCT/IB2011/002346 WO2012010973A2 (en) 2010-07-21 2011-07-15 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition

Publications (2)

Publication Number Publication Date
CA2805978A1 CA2805978A1 (en) 2012-01-26
CA2805978C true CA2805978C (en) 2016-06-28

Family

ID=44899162

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2805978A Expired - Fee Related CA2805978C (en) 2010-07-21 2011-07-15 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition

Country Status (22)

Country Link
US (2) US8795657B2 (enExample)
EP (1) EP2595655A2 (enExample)
JP (2) JP2013533269A (enExample)
CN (1) CN103200964A (enExample)
AR (1) AR082313A1 (enExample)
AU (1) AU2011281247B2 (enExample)
BR (1) BR112013001297A2 (enExample)
CA (1) CA2805978C (enExample)
CL (1) CL2013000202A1 (enExample)
DE (1) DE112011102412T5 (enExample)
EA (1) EA029228B1 (enExample)
ES (1) ES2425315R1 (enExample)
FR (1) FR2962909A1 (enExample)
GB (1) GB2496800B (enExample)
IT (1) ITTO20110638A1 (enExample)
MX (1) MX356678B (enExample)
MY (1) MY158522A (enExample)
NZ (1) NZ606977A (enExample)
PE (1) PE20130387A1 (enExample)
PH (1) PH12013500142A1 (enExample)
SG (1) SG187579A1 (enExample)
WO (1) WO2012010973A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US8637034B2 (en) 2010-07-15 2014-01-28 Oleg I. Epshtein Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein
EA030566B1 (ru) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция
CA2805963A1 (en) 2010-07-21 2012-01-26 Oleg Iliich Epshtein A method of treating attention deficit hyperactivity disorder
KR20130102542A (ko) * 2010-07-21 2013-09-17 올레그 일리치 엡쉬테인 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들
PH12013500142A1 (en) * 2010-07-21 2013-03-11 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
EP3693018A1 (en) * 2010-07-21 2020-08-12 Oleg Iliich Epshtein A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
WO2012017328A2 (en) * 2010-08-06 2012-02-09 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
RU2013111962A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
RU2013111961A (ru) 2013-03-18 2014-09-27 Олег Ильич Эпштейн Способ определения выраженности модифицирующей активности, ассоциированной с носителем
DE102020007979A1 (de) 2020-12-29 2022-06-30 Charité Universitätsmedizin Institut für Mikrobiologie und Infektionsimmunologie Zusammensetzung zur Behandlung von lnfektionen mit Coronaviren

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311897A (en) 1979-08-28 1982-01-19 Union Carbide Corporation Plasma arc torch and nozzle assembly
WO1994008619A1 (en) 1992-10-08 1994-04-28 The Kennedy Institute Of Rheumatology Treatment of autoimmune and inflammatory disorders
IT1261849B (it) 1993-09-02 1996-06-03 Avantgarde Spa Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
US5629286A (en) 1994-03-31 1997-05-13 Brewitt; Barbara Homeopathic dilutions of growth factors
IL110035A0 (en) 1994-06-16 1994-10-07 Tapuach Natural Technologies 1 Homeopathic formulations
CN1141929C (zh) 1996-02-12 2004-03-17 O·I·伊普施廷 药物制剂
US5834443A (en) * 1996-05-21 1998-11-10 Masiello; Domenick J. Composition and method for treating herpes simplex
RU2114646C1 (ru) 1996-09-30 1998-07-10 Олег Ильич Эпштейн Способ повышения защитных свойств организма при воздействии внешних физических факторов
RU2103999C1 (ru) 1997-01-31 1998-02-10 Олег Ильич Эпштейн Способ лечения алкоголизма
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
RU2199244C2 (ru) * 2000-10-05 2003-02-27 Самофалова Лариса Александровна Способ получения пищевой муки масличных семян
RU2197266C1 (ru) * 2001-06-01 2003-01-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения эрозивных и воспалительных заболеваний желудочно-кишечного тракта
RU2191602C1 (ru) 2001-06-01 2002-10-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения аллергических и псевдоаллергических реакций
RU2199344C1 (ru) * 2001-12-07 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения синдрома кашля
RU2206338C1 (ru) 2001-12-07 2003-06-20 Эпштейн Олег Ильич Способ лечения синдрома кашля
RU2199345C1 (ru) 2001-12-26 2003-02-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции углеводного и жирового обмена
RU2201255C1 (ru) 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
RU2209083C1 (ru) 2001-12-26 2003-07-27 Эпштейн Олег Ильич Лекарственное средство и способ лечения кашля
UA76641C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76638C2 (en) 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
CA2518965C (en) 2003-03-14 2018-10-30 Nutrition Research Inc. Homeopathic formulations useful for treating pain and/or inflammmation
RU2253478C1 (ru) 2003-10-01 2005-06-10 Эпштейн Олег Ильич Средство для потенцирования лечебных эффектов - усиления действия лекарственного вещества
EA200802440A1 (ru) * 2006-06-06 2009-06-30 Олег Ильич ЭПШТЕЙН Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе
JP2011518876A (ja) * 2008-04-29 2011-06-30 ガンヴァント、 デビチャンド オスワル、 ホメオパシー製剤
ITTO20110641A1 (it) * 2010-07-15 2012-01-16 Oleg Iliich Epshtein Composizioni farmaceutiche e metodi di trattamento
US8637034B2 (en) * 2010-07-15 2014-01-28 Oleg I. Epshtein Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein
EA030542B1 (ru) 2010-07-15 2018-08-31 Олег Ильич ЭПШТЕЙН Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
CN103282384A (zh) 2010-07-15 2013-09-04 奥列格·伊里奇·爱泼斯坦 复合药物组合物以及对泌尿生殖系统障碍进行治疗的方法
EP3693018A1 (en) * 2010-07-21 2020-08-12 Oleg Iliich Epshtein A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders
KR20130102542A (ko) 2010-07-21 2013-09-17 올레그 일리치 엡쉬테인 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들
PH12013500142A1 (en) * 2010-07-21 2013-03-11 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
WO2012017328A2 (en) 2010-08-06 2012-02-09 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating and preventing the infectious diseases

Also Published As

Publication number Publication date
JP2016216479A (ja) 2016-12-22
GB201302926D0 (en) 2013-04-03
GB2496800B (en) 2018-05-23
MX356678B (es) 2018-06-08
EA201300131A1 (ru) 2013-11-29
MX2013000806A (es) 2013-10-28
EA029228B1 (ru) 2018-02-28
ES2425315A2 (es) 2013-10-14
SG187579A1 (en) 2013-03-28
NZ606977A (en) 2015-08-28
PH12013500142A1 (en) 2013-03-11
US8795657B2 (en) 2014-08-05
FR2962909A1 (fr) 2012-01-27
WO2012010973A3 (en) 2012-04-26
AR082313A1 (es) 2012-11-28
BR112013001297A2 (pt) 2017-11-21
PE20130387A1 (es) 2013-03-30
EP2595655A2 (en) 2013-05-29
MY158522A (en) 2016-10-14
ITTO20110638A1 (it) 2012-01-22
CL2013000202A1 (es) 2015-01-16
CN103200964A (zh) 2013-07-10
WO2012010973A2 (en) 2012-01-26
US20150023985A1 (en) 2015-01-22
JP2013533269A (ja) 2013-08-22
US20120225074A1 (en) 2012-09-06
AU2011281247B2 (en) 2015-07-30
ES2425315R1 (es) 2014-09-08
GB2496800A (en) 2013-05-22
AU2011281247A1 (en) 2013-03-14
DE112011102412T5 (de) 2013-07-04
CA2805978A1 (en) 2012-01-26

Similar Documents

Publication Publication Date Title
AU2011281247B2 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
US8168182B2 (en) Method for treating erectile dysfunction
RU2309732C1 (ru) Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US20170121400A1 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
BRPI0712540A2 (pt) agente medicinal para tratar adiposidade, diabetes, e doenças associadas com intoleráncia a glicose
US20130045237A1 (en) Combination pharmaceutical composition and methods of treating and preventing the infectious diseases
CN103124742A (zh) 药物组合物和治疗方法
US20130064860A1 (en) Combination pharmaceutical composition and methods of theating genitourinary system disorders
US8703124B2 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
CN103119060A (zh) 治疗阿尔兹海默病的方法
CN103119061A (zh) 治疗注意力不足过动症的方法
DK201370079A (en) A method of increasing the effect of an activated-potentiated form of an antibody
RU2517085C2 (ru) Комплексное лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
CN109985120A (zh) 一种治疗湿疹的中药组合物及其应用
RU2529783C2 (ru) Лекарственное средство для лечения патологического синдрома и способ лечения острых и хронических заболеваний дыхательноый системы и синдрома кашля
UA112754C2 (uk) Комбінована фармацевтична композиція та методи лікування хвороб або станів, пов'язаних з респіраторними захворюваннями
RU2502521C2 (ru) Комплексное лекарственное средство для лечения бактериальных инфекций и способ лечения бактериальных инфекций
RU2651005C2 (ru) Способ повышения фармакологической активности активированной-потенцированной формы антител к простатоспецифическому антигену и фармацевтическая композиция
RU2542414C2 (ru) Лекарственное средство для лечения эректильных дисфункций и способ лечения эректильных дисфункций

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140811

MKLA Lapsed

Effective date: 20220301

MKLA Lapsed

Effective date: 20200831